One such example is that of the co-amplification of STIM1 in pancreatic cancer cells upon the acquisition of gemcitabine resistance, which elicits a shift in calcium signaling and transcription factor dependencies [5]. This evidence concerns the gene STIM1 and familial pancreatic carcinoma.